APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psychobiotic Supplements

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Psychobiotic Supplements Industry Growth and Trends Forecast to 2032

30 December 2025106 pages

Choose your research edition.

Industry ResearchPsychobiotic Supplements Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Psychobiotic Supplements Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Psychobiotic Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psychobiotic Supplements Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Psychobiotic Supplements Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psychobiotic Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psychobiotic Supplements include Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics and SFI Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Psychobiotic Supplements market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Psychobiotic Supplements market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Psychobiotic Supplements market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Psychobiotic Supplements.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Psychobiotic Supplements market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Psychobiotic Supplements Market by Company

Life Extension

Lifted Naturals

NEURAXPHARM

Uplift Food Pty Ltd.

Nutrimmun GmbH

InnovixLabs

Optibac Probiotics

Seraphina Therapeutics

SFI Health

Microbiome Labs

G1 NUTRITION

Psychobiotic Supplements Segment by Type

Capsules

Tablets

Other

Psychobiotic Supplements Segment by Application

Offline Sales

Online Sales

Psychobiotic Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychobiotic Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psychobiotic Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychobiotic Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psychobiotic Supplements manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Psychobiotic Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Tablets Table 3. Major Company of Other Table 4. Global Psychobiotic Supplements Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 6. Global Psychobiotic Supplements Sales Market Share in Volume by Type (2021-2026) Table 7. Global Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 8. Global Psychobiotic Supplements Sales Market Share in Value by Type (2021-2026) Table 9. Global Psychobiotic Supplements Price by Type (2021-2026) & (USD/unit) Table 10. Global Psychobiotic Supplements Sales by Type (2027-2032) & (k units) Table 11. Global Psychobiotic Supplements Sales Market Share in Volume by Type (2027-2032) Table 12. Global Psychobiotic Supplements Sales by Type (2027-2032) & (US$ Million) Table 13. Global Psychobiotic Supplements Sales Market Share in Value by Type (2027-2032) Table 14. Global Psychobiotic Supplements Price by Type (2027-2032) & (USD/unit) Table 15. North America Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 16. North America Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 18. Europe Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 22. Latin America Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Psychobiotic Supplements Sales by Type (2021-2026) & (US$ Million) Table 25. Psychobiotic Supplements Industry Trends Table 26. Psychobiotic Supplements Industry Drivers Table 27. Psychobiotic Supplements Industry Opportunities and Challenges Table 28. Psychobiotic Supplements Industry Restraints Table 29. Global Psychobiotic Supplements Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Psychobiotic Supplements Revenue Market Share by Company (2021-2026) Table 31. Global Psychobiotic Supplements Sales by Company (2021-2026) & (k units) Table 32. Global Psychobiotic Supplements Sales Share by Company (2021-2026) Table 33. Global Psychobiotic Supplements Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Psychobiotic Supplements Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Psychobiotic Supplements Major Company Production Sites and Headquarters Table 36. Global Psychobiotic Supplements Company, Product Type & Application Table 37. Global Psychobiotic Supplements Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Psychobiotic Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Psychobiotic Supplements Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Psychobiotic Supplements Sales by Region (2021-2026) & (k units) Table 42. Global Psychobiotic Supplements Sales Market Share in Volume by Region (2021-2026) Table 43. Global Psychobiotic Supplements Sales by Region (2021-2026) & (US$ Million) Table 44. Global Psychobiotic Supplements Sales Market Share in Value by Region (2021-2026) Table 45. Global Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Psychobiotic Supplements Sales by Region (2027-2032) & (k units) Table 47. Global Psychobiotic Supplements Sales Market Share in Volume by Region (2027-2032) Table 48. Global Psychobiotic Supplements Sales by Region (2027-2032) & (US$ Million) Table 49. Global Psychobiotic Supplements Sales Market Share in Value by Region (2027-2032) Table 50. Global Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Psychobiotic Supplements Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 53. Global Psychobiotic Supplements Sales Market Share in Volume by Application (2021-2026) Table 54. Global Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 55. Global Psychobiotic Supplements Sales Market Share in Value by Application (2021-2026) Table 56. Global Psychobiotic Supplements Price by Application (2021-2026) & (USD/unit) Table 57. Global Psychobiotic Supplements Sales by Application (2027-2032) & (k units) Table 58. Global Psychobiotic Supplements Sales Market Share in Volume by Application (2027-2032) Table 59. Global Psychobiotic Supplements Sales by Application (2027-2032) & (US$ Million) Table 60. Global Psychobiotic Supplements Sales Market Share in Value by Application (2027-2032) Table 61. Global Psychobiotic Supplements Price by Application (2027-2032) & (USD/unit) Table 62. North America Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 63. North America Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 65. Europe Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 69. Latin America Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Psychobiotic Supplements Sales by Application (2021-2026) & (US$ Million) Table 72. Life Extension Company Information Table 73. Life Extension Business Overview Table 74. Life Extension Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Life Extension Psychobiotic Supplements Product Portfolio Table 76. Life Extension Recent Development Table 77. Lifted Naturals Company Information Table 78. Lifted Naturals Business Overview Table 79. Lifted Naturals Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Lifted Naturals Psychobiotic Supplements Product Portfolio Table 81. Lifted Naturals Recent Development Table 82. NEURAXPHARM Company Information Table 83. NEURAXPHARM Business Overview Table 84. NEURAXPHARM Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. NEURAXPHARM Psychobiotic Supplements Product Portfolio Table 86. NEURAXPHARM Recent Development Table 87. Uplift Food Pty Ltd. Company Information Table 88. Uplift Food Pty Ltd. Business Overview Table 89. Uplift Food Pty Ltd. Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio Table 91. Uplift Food Pty Ltd. Recent Development Table 92. Nutrimmun GmbH Company Information Table 93. Nutrimmun GmbH Business Overview Table 94. Nutrimmun GmbH Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Nutrimmun GmbH Psychobiotic Supplements Product Portfolio Table 96. Nutrimmun GmbH Recent Development Table 97. InnovixLabs Company Information Table 98. InnovixLabs Business Overview Table 99. InnovixLabs Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. InnovixLabs Psychobiotic Supplements Product Portfolio Table 101. InnovixLabs Recent Development Table 102. Optibac Probiotics Company Information Table 103. Optibac Probiotics Business Overview Table 104. Optibac Probiotics Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Optibac Probiotics Psychobiotic Supplements Product Portfolio Table 106. Optibac Probiotics Recent Development Table 107. Seraphina Therapeutics Company Information Table 108. Seraphina Therapeutics Business Overview Table 109. Seraphina Therapeutics Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Seraphina Therapeutics Psychobiotic Supplements Product Portfolio Table 111. Seraphina Therapeutics Recent Development Table 112. SFI Health Company Information Table 113. SFI Health Business Overview Table 114. SFI Health Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. SFI Health Psychobiotic Supplements Product Portfolio Table 116. SFI Health Recent Development Table 117. Microbiome Labs Company Information Table 118. Microbiome Labs Business Overview Table 119. Microbiome Labs Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Microbiome Labs Psychobiotic Supplements Product Portfolio Table 121. Microbiome Labs Recent Development Table 122. G1 NUTRITION Company Information Table 123. G1 NUTRITION Business Overview Table 124. G1 NUTRITION Psychobiotic Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. G1 NUTRITION Psychobiotic Supplements Product Portfolio Table 126. G1 NUTRITION Recent Development Table 127. North America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 129. North America Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 130. North America Psychobiotic Supplements Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Psychobiotic Supplements Sales Market Share Forecast by Country (2027-2032) Table 132. North America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Psychobiotic Supplements Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Psychobiotic Supplements Market Share by Country (2021-2026) Table 135. North America Psychobiotic Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Psychobiotic Supplements Market Share Forecast by Country (2027-2032) Table 137. Europe Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 139. Europe Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 140. Europe Psychobiotic Supplements Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Psychobiotic Supplements Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Psychobiotic Supplements Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Psychobiotic Supplements Market Share by Country (2021-2026) Table 145. Europe Psychobiotic Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Psychobiotic Supplements Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Psychobiotic Supplements Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Psychobiotic Supplements Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Psychobiotic Supplements Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Psychobiotic Supplements Market Share by Country (2021-2026) Table 155. Asia-Pacific Psychobiotic Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Psychobiotic Supplements Market Share Forecast by Country (2027-2032) Table 157. Latin America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 159. Latin America Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 160. Latin America Psychobiotic Supplements Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Psychobiotic Supplements Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Psychobiotic Supplements Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Psychobiotic Supplements Market Share by Country (2021-2026) Table 165. Latin America Psychobiotic Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Psychobiotic Supplements Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Psychobiotic Supplements Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Psychobiotic Supplements Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Psychobiotic Supplements Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Psychobiotic Supplements Market Share by Country (2021-2026) Table 175. Middle East and Africa Psychobiotic Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Psychobiotic Supplements Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Psychobiotic Supplements Distributors List Table 180. Psychobiotic Supplements Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Psychobiotic Supplements Image Figure 2. Global Psychobiotic Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psychobiotic Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Psychobiotic Supplements Sales (2021-2032) & (k units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (k units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Psychobiotic Supplements Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Psychobiotic Supplements Market Share by Type 2025 VS 2032 Figure 13. North America Psychobiotic Supplements Sales Market Share in Volume by Type in 2025 Figure 14. North America Psychobiotic Supplements Sales Market Share in Value by Type in 2025 Figure 15. Europe Psychobiotic Supplements Sales Market Share in Volume by Type in 2025 Figure 16. Europe Psychobiotic Supplements Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Psychobiotic Supplements Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Psychobiotic Supplements Sales Market Share in Value by Type in 2025 Figure 19. Latin America Psychobiotic Supplements Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Psychobiotic Supplements Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Psychobiotic Supplements Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Psychobiotic Supplements Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Psychobiotic Supplements Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Offline Sales Image Figure 26. Global Offline Sales Sales YoY Growth (2021-2032) & (k units) Figure 27. Online Sales Image Figure 28. Global Online Sales Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Psychobiotic Supplements Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Psychobiotic Supplements Market Share by Application 2025 VS 2032 Figure 31. North America Psychobiotic Supplements Sales Market Share in Volume by Application in 2025 Figure 32. North America Psychobiotic Supplements Sales Market Share in Value by Application in 2025 Figure 33. Europe Psychobiotic Supplements Sales Market Share in Volume by Application in 2025 Figure 34. Europe Psychobiotic Supplements Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Psychobiotic Supplements Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Psychobiotic Supplements Sales Market Share in Value by Application in 2025 Figure 37. Latin America Psychobiotic Supplements Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Psychobiotic Supplements Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Psychobiotic Supplements Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Psychobiotic Supplements Sales Market Share in Value by Application in 2025 Figure 41. North America Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Psychobiotic Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Psychobiotic Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Psychobiotic Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Psychobiotic Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Psychobiotic Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Psychobiotic Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Psychobiotic Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Psychobiotic Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Psychobiotic Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Psychobiotic Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Psychobiotic Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Psychobiotic Supplements Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Psychobiotic Supplements Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
  • Other
Applications
  • Offline Sales
  • Online Sales
Companies covered
  • Life Extension
  • Lifted Naturals
  • NEURAXPHARM
  • Uplift Food Pty Ltd.
  • Nutrimmun GmbH
  • InnovixLabs
  • Optibac Probiotics
  • Seraphina Therapeutics
  • SFI Health
  • Microbiome Labs
  • G1 NUTRITION

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Psychobiotic Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Psychobiotic Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Psychobiotic Supplements Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Tablets
  8. 1.3.3 Other
  9. 1.4 Global Psychobiotic Supplements Market Size by Type
  10. 1.4.1 Global Psychobiotic Supplements Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Psychobiotic Supplements Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Psychobiotic Supplements Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Psychobiotic Supplements Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Psychobiotic Supplements Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Psychobiotic Supplements Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Psychobiotic Supplements Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Psychobiotic Supplements Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Psychobiotic Supplements Industry Trends
  2. 2.2 Psychobiotic Supplements Industry Drivers
  3. 2.3 Psychobiotic Supplements Industry Opportunities and Challenges
  4. 2.4 Psychobiotic Supplements Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Psychobiotic Supplements Revenue (2021-2026)
  2. 3.2 Global Top Players by Psychobiotic Supplements Sales (2021-2026)
  3. 3.3 Global Top Players by Psychobiotic Supplements Price (2021-2026)
  4. 3.4 Global Psychobiotic Supplements Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psychobiotic Supplements Major Company Production Sites & Headquarters
  6. 3.6 Global Psychobiotic Supplements Company, Product Type & Application
  7. 3.7 Global Psychobiotic Supplements Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psychobiotic Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psychobiotic Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psychobiotic Supplements Tier 1, Tier 2, and Tier 3
4 Psychobiotic Supplements Regional Status and Outlook
  1. 4.1 Global Psychobiotic Supplements Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Psychobiotic Supplements Historic Market Size by Region
  3. 4.2.1 Global Psychobiotic Supplements Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Psychobiotic Supplements Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Psychobiotic Supplements Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Psychobiotic Supplements Forecasted Market Size by Region
  7. 4.3.1 Global Psychobiotic Supplements Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Psychobiotic Supplements Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Psychobiotic Supplements Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Psychobiotic Supplements by Application
  1. 5.1 Psychobiotic Supplements Market by Application
  2. 5.1.1 Offline Sales
  3. 5.1.2 Online Sales
  4. 5.2 Global Psychobiotic Supplements Market Size by Application
  5. 5.2.1 Global Psychobiotic Supplements Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Psychobiotic Supplements Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Psychobiotic Supplements Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Psychobiotic Supplements Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Psychobiotic Supplements Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Psychobiotic Supplements Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Psychobiotic Supplements Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Psychobiotic Supplements Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Life Extension
  2. 6.1.1 Life Extension Company Information
  3. 6.1.2 Life Extension Business Overview
  4. 6.1.3 Life Extension Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Life Extension Psychobiotic Supplements Product Portfolio
  6. 6.1.5 Life Extension Recent Developments
  7. 6.2 Lifted Naturals
  8. 6.2.1 Lifted Naturals Company Information
  9. 6.2.2 Lifted Naturals Business Overview
  10. 6.2.3 Lifted Naturals Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lifted Naturals Psychobiotic Supplements Product Portfolio
  12. 6.2.5 Lifted Naturals Recent Developments
  13. 6.3 NEURAXPHARM
  14. 6.3.1 NEURAXPHARM Company Information
  15. 6.3.2 NEURAXPHARM Business Overview
  16. 6.3.3 NEURAXPHARM Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NEURAXPHARM Psychobiotic Supplements Product Portfolio
  18. 6.3.5 NEURAXPHARM Recent Developments
  19. 6.4 Uplift Food Pty Ltd.
  20. 6.4.1 Uplift Food Pty Ltd. Company Information
  21. 6.4.2 Uplift Food Pty Ltd. Business Overview
  22. 6.4.3 Uplift Food Pty Ltd. Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio
  24. 6.4.5 Uplift Food Pty Ltd. Recent Developments
  25. 6.5 Nutrimmun GmbH
  26. 6.5.1 Nutrimmun GmbH Company Information
  27. 6.5.2 Nutrimmun GmbH Business Overview
  28. 6.5.3 Nutrimmun GmbH Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nutrimmun GmbH Psychobiotic Supplements Product Portfolio
  30. 6.5.5 Nutrimmun GmbH Recent Developments
  31. 6.6 InnovixLabs
  32. 6.6.1 InnovixLabs Company Information
  33. 6.6.2 InnovixLabs Business Overview
  34. 6.6.3 InnovixLabs Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 InnovixLabs Psychobiotic Supplements Product Portfolio
  36. 6.6.5 InnovixLabs Recent Developments
  37. 6.7 Optibac Probiotics
  38. 6.7.1 Optibac Probiotics Company Information
  39. 6.7.2 Optibac Probiotics Business Overview
  40. 6.7.3 Optibac Probiotics Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Optibac Probiotics Psychobiotic Supplements Product Portfolio
  42. 6.7.5 Optibac Probiotics Recent Developments
  43. 6.8 Seraphina Therapeutics
  44. 6.8.1 Seraphina Therapeutics Company Information
  45. 6.8.2 Seraphina Therapeutics Business Overview
  46. 6.8.3 Seraphina Therapeutics Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Seraphina Therapeutics Psychobiotic Supplements Product Portfolio
  48. 6.8.5 Seraphina Therapeutics Recent Developments
  49. 6.9 SFI Health
  50. 6.9.1 SFI Health Company Information
  51. 6.9.2 SFI Health Business Overview
  52. 6.9.3 SFI Health Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SFI Health Psychobiotic Supplements Product Portfolio
  54. 6.9.5 SFI Health Recent Developments
  55. 6.10 Microbiome Labs
  56. 6.10.1 Microbiome Labs Company Information
  57. 6.10.2 Microbiome Labs Business Overview
  58. 6.10.3 Microbiome Labs Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Microbiome Labs Psychobiotic Supplements Product Portfolio
  60. 6.10.5 Microbiome Labs Recent Developments
  61. 6.11 G1 NUTRITION
  62. 6.11.1 G1 NUTRITION Company Information
  63. 6.11.2 G1 NUTRITION Business Overview
  64. 6.11.3 G1 NUTRITION Psychobiotic Supplements Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 G1 NUTRITION Psychobiotic Supplements Product Portfolio
  66. 6.11.5 G1 NUTRITION Recent Developments
7 North America by Country
  1. 7.1 North America Psychobiotic Supplements Sales by Country
  2. 7.1.1 North America Psychobiotic Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Psychobiotic Supplements Sales by Country (2021-2026)
  4. 7.1.3 North America Psychobiotic Supplements Sales Forecast by Country (2027-2032)
  5. 7.2 North America Psychobiotic Supplements Market Size by Country
  6. 7.2.1 North America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Psychobiotic Supplements Market Size by Country (2021-2026)
  8. 7.2.3 North America Psychobiotic Supplements Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Psychobiotic Supplements Sales by Country
  2. 8.1.1 Europe Psychobiotic Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Psychobiotic Supplements Sales by Country (2021-2026)
  4. 8.1.3 Europe Psychobiotic Supplements Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Psychobiotic Supplements Market Size by Country
  6. 8.2.1 Europe Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Psychobiotic Supplements Market Size by Country (2021-2026)
  8. 8.2.3 Europe Psychobiotic Supplements Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Psychobiotic Supplements Sales by Country
  2. 9.1.1 Asia-Pacific Psychobiotic Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Psychobiotic Supplements Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Psychobiotic Supplements Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Psychobiotic Supplements Market Size by Country
  6. 9.2.1 Asia-Pacific Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Psychobiotic Supplements Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Psychobiotic Supplements Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Psychobiotic Supplements Sales by Country
  2. 10.1.1 South America Psychobiotic Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Psychobiotic Supplements Sales by Country (2021-2026)
  4. 10.1.3 South America Psychobiotic Supplements Sales Forecast by Country (2027-2032)
  5. 10.2 South America Psychobiotic Supplements Market Size by Country
  6. 10.2.1 South America Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Psychobiotic Supplements Market Size by Country (2021-2026)
  8. 10.2.3 South America Psychobiotic Supplements Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Psychobiotic Supplements Sales by Country
  2. 11.1.1 Middle East and Africa Psychobiotic Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Psychobiotic Supplements Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Psychobiotic Supplements Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Psychobiotic Supplements Market Size by Country
  6. 11.2.1 Middle East and Africa Psychobiotic Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Psychobiotic Supplements Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Psychobiotic Supplements Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Psychobiotic Supplements Value Chain Analysis
  2. 12.1.1 Psychobiotic Supplements Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Psychobiotic Supplements Production Mode & Process
  7. 12.2 Psychobiotic Supplements Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Psychobiotic Supplements Distributors
  10. 12.2.3 Psychobiotic Supplements Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst